Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib Read more about Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) Read more about Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)
A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) Read more about A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy Read more about FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency Read more about Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
InterStim Micro Post Market Clinical Follow-up Study Read more about InterStim Micro Post Market Clinical Follow-up Study
A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS Read more about A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
Prevalence of Carbohydrate Intolerance in Lean and Obese Children Read more about Prevalence of Carbohydrate Intolerance in Lean and Obese Children
ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) Read more about ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants Read more about Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants